Ingenix announces formation of new Life Sciences division

Ingenix, a leading provider of health care information, technology and consulting services, today announced the formation of Ingenix Life Sciences, a newly-organized division that focuses Ingenix's capabilities in assisting life sciences clients to identify, analyze and measure the value of their products.

“This new Ingenix Life Sciences division helps sharpen our focus on what we do best: helping pharmaceutical, biotech and medical device companies address the changing global competitive, economic and regulatory landscape, to demonstrate the comparative effectiveness and value of their products earlier in the commercialization process.”

As part of focusing on its distinct life sciences competencies, Ingenix is exiting the Phase II - III clinical trial support business and intends to sell these clinical development businesses to inVentiv Health.

Ingenix Life Sciences will continue to offer global solutions for evaluating health economics outcomes and late phase research, market access and reimbursement, data and informatics services, epidemiology and drug safety, patient-reported outcomes and regulatory consulting. The current Innovus, Quality Metric, Pharma Informatics, and Drug Safety/Epidemiology business units, and the CanReg and ChinaGate Regulatory Consulting businesses will be part of Ingenix Life Sciences.

Lee Valenta, who has served as chief operating officer of Ingenix for the past five years, has been named President of Ingenix Life Sciences, which will include more than 600 expert professionals worldwide.

Mr. Valenta said, "This new Ingenix Life Sciences division helps sharpen our focus on what we do best: helping pharmaceutical, biotech and medical device companies address the changing global competitive, economic and regulatory landscape, to demonstrate the comparative effectiveness and value of their products earlier in the commercialization process."

Ingenix will continue to invest in the expertise and proprietary capabilities of Ingenix Life Sciences to further build Ingenix's core strengths in health intelligence, connectivity and workflow. Over the last several years Ingenix has built a very distinct platform for serving the life sciences industry that closely aligns with its work on behalf of clients throughout the rest of the health ecosystem - health care providers, payers and governments. Ingenix Life Sciences is a key component of Ingenix's ability to enable collaboration across health care communities to improve quality, efficiency and overall health for patients.